P. Pepe, “Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy”, Arch Ital Urol Androl, vol. 88, no. 4, pp. 300–303, Dec. 2016.